Closed
Previous-day view · Fri Nov 6 close. You are previewing the previous trading day. Subscribe to see today live and every other date — Trader is $59/mo. Sign up Sign in
Transactions disclosed · Nov 6
1236

Latest filing Nov 6, 2026 Latest trade Nov 6, 2026

Disclosed buying · 14d
$1.03B

788 purchases across 244 tickers

Disclosed selling · 14d
$5.91B

4781 sales and dispositions

Tape lean · 14d
Heavy selling

Largest buy: ROL $49.96M

Disclosure flow

Value filed per session · last 60 days

Where the money went

By disclosed value · 14 days · click a bar for the filings
Most bought
Most sold

144,929 transactions

Insider Trades
Filed Transaction Issuer / asset Insider Qty / price Value Source Actions
Nov 4, 2026 1-day lag Exercise Nov 3, 2026 Stock option (right to buy) on Common Stock Maduck Sean Other 13,159 shares @ $0 Direct ownership $0 SEC Form 4
Same filing as the row above Sale Nov 3, 2026 Common Stock 4,542 shares @ $82.68 Direct ownership $375.51K
Same filing as the row above Exercise Nov 3, 2026 13,159 shares @ $8.27 Direct ownership $108.82K
Same filing as the row above Sale Nov 2, 2026 11,841 shares @ $81.42 Direct ownership $964.07K
Same filing as the row above Exercise Nov 2, 2026 Stock option (right to buy) on Common Stock 11,841 shares @ $0 Direct ownership $0
Same filing as the row above Exercise Nov 2, 2026 Common Stock 11,841 shares @ $8.27 Direct ownership $97.93K
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Kleinerman Christian EVP, Product Management 10,000 shares @ $306.01 Direct ownership $3.06M SEC Form 4
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Vieira Roberto Wandenkolk President, Oncology 6,657 shares @ $80.73 Direct ownership $537.44K SEC Form 4
Same filing as the row above Exercise Nov 2, 2026 8,333 shares @ $21.63 Direct ownership $180.24K
Same filing as the row above Sale Nov 2, 2026 1,676 shares @ $81.52 Direct ownership $136.63K
Same filing as the row above Exercise Nov 2, 2026 Stock option (right to buy) on Common Stock 8,333 shares @ $0 Direct ownership $0
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Class A-1 Common Stock Phelan Mark T. President And CEO 25,000 shares @ $12 Direct ownership $300K SEC Form 4
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Anschutz Barron Other 10,000 shares @ $51 Direct ownership $510K SEC Form 4
Nov 4, 2026 2-day lag Exercise Nov 2, 2026 Stock Option (right to buy) on Common Stock Seawell A Brooke Director 115,000 shares @ $0 Direct ownership $0 SEC Form 4
Same filing as the row above Sale Nov 2, 2026 Common Stock 15,000 shares @ $48.73 Indirect ownership $730.95K
Same filing as the row above Sale Nov 2, 2026 15,000 shares @ $50.33 Direct ownership $754.95K
Same filing as the row above Exercise Nov 2, 2026 115,000 shares @ $9.66 Direct ownership $1.11M
Nov 4, 2026 2-day lag Sale Nov 2, 2026 Common Stock Bales Brian A EVP, Chief Development Officer 3,400 shares @ $244 Indirect ownership $829.6K SEC Form 4
Nov 4, 2026 5-day lag Award Oct 30, 2026 Common Stock Tkachenko Igor VP, Corporate Strategy 15,419 shares @ $0 Direct ownership $0 SEC Form 4
Nov 4, 2026 2-day lag Award Nov 2, 2026 Performance Right on Common Stock Honroth Eric President And CEO 62,928 shares @ $0 Direct ownership $0 SEC Form 4
Same filing as the row above Award Nov 2, 2026 Common Stock 38,265 shares @ $0 Direct ownership $0
Same filing as the row above Award Nov 2, 2026 62,928 shares @ $0 Direct ownership $0
Nov 4, 2026 2-day lag Conversion Nov 2, 2026 Series A-2 Convertible Preferred Stock on Com... Thompson Peter A. Director / Ten Percent Owner 616,984 shares @ $0 Indirect ownership $0 SEC Form 4
Same filing as the row above Conversion Nov 2, 2026 Series A-1 Convertible Preferred Stock on Common Stock 642,745 shares @ $0 Indirect ownership $0
Same filing as the row above Conversion Nov 2, 2026 Common Stock 196,541 shares Indirect ownership Not reported
Kleinerman Christian EVP, Product Management
Sale
Calculated transaction value
$3.06M
Traded
Nov 2, 2026
Filed
Nov 4, 2026
Quantity / price
10,000 shares @ $306.01